Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4547498
Max Phase: Preclinical
Molecular Formula: C17H27N
Molecular Weight: 245.41
Molecule Type: Unknown
Associated Items:
ID: ALA4547498
Max Phase: Preclinical
Molecular Formula: C17H27N
Molecular Weight: 245.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(C)C(=C\C=C\CN)/C=C/C1=CCCCC1
Standard InChI: InChI=1S/C17H27N/c1-17(2,3)16(11-7-8-14-18)13-12-15-9-5-4-6-10-15/h7-9,11-13H,4-6,10,14,18H2,1-3H3/b8-7+,13-12+,16-11-
Standard InChI Key: RZCQPTPJQUGXOC-NKNDRUNPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 245.41 | Molecular Weight (Monoisotopic): 245.2143 | AlogP: 4.53 | #Rotatable Bonds: 4 |
Polar Surface Area: 26.02 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.64 | CX LogP: 4.02 | CX LogD: 1.84 |
Aromatic Rings: 0 | Heavy Atoms: 18 | QED Weighted: 0.72 | Np Likeness Score: 0.66 |
1. (2017) Compounds and methods of treating ocular disorders, |
Source(1):